Paper363377
Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion.
Chabner BA and 4 others. Drug Metab Rev, 1978. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion. Papers, record 363377. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/363377
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methotrexate | Major topic |
| Ovarian Neoplasms | Major topic |
| Ascites | |
| Drug Resistance | |
| Female | |
| Humans | |
| Infusions, Parenteral | |
| Kinetics |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39527259 | Periprosthetic seromas and a third space effect after high-dose methotrexate. | Wien Klin Wochenschr | 2025 | https://conductscience.org/library/papers/39527259 | PubMed |
| 38440732 | Endoplasmic reticulum stress in breast cancer: a predictive model for prognosis and therapy selection. | Front Immunol | 2024 | https://conductscience.org/library/papers/38440732 | PubMed |
| 35610338 | Molecular relation between biological stress and carcinogenesis. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35610338 | PubMed |
| 11368290 | All half-lives are wrong, but some half-lives are useful. | Clin Pharmacokinet | 2001 | https://conductscience.org/library/papers/11368290 | PubMed |
| 3370743 | The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3370743 | PubMed |
| 3052986 | Clinical pharmacokinetics of drugs used in the treatment of breast cancer. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3052986 | PubMed |
| 2689182 | The effects of diltiazem on methotrexate-induced nephrotoxicity. | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2689182 | PubMed |
| 527209 | High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/527209 | PubMed |
| 373916 | High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results. | Cancer Chemother Pharmacol | 1978 | https://conductscience.org/library/papers/373916 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/363377
GET https://conductscience.org/api/papers/v1/363377/authors